Irene Taw, MD, Radiation Oncology, Glendale, AZ, HonorHealth Scottsdale Osborn Medical Center


Radiation Oncology Glendale, AZ

Breast Cancer, Thoracic Cancer, Urologic Cancer


Dr. Taw is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Taw's full profile

Already have an account?

Education & Training

  • University of Tennessee
    University of TennesseeMBA, Physician Executive, 2012
  • Rush University Medical Center
    Rush University Medical CenterResidency, Radiation Oncology, 1992 - 1996
  • Chicago Medical School at Rosalind Franklin University
    Chicago Medical School at Rosalind Franklin UniversityClass of 1992
  • University of CaliforniaBS, Biochemistry, 1983 - 1987

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1998 - 2022
  • IL State Medical License
    IL State Medical License 1992 - 1999
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
  • Top Doctor Phoenix Magazine, 2009, 2011
  • Best Doctor Best Doctor Inc., 2005
  • Join now to see all

Publications & Presentations


Journal Articles

  • Radiation Toxicity of the Lung  
    Taw, I., Hartsell W., Rubin, D, Clinical Pulmonary Medicine, 1/1/1995
  • Intratumor Heterogeneity of DNA Ploidy and Correlations with Clinical Stage and Histologic Grade in Prostate Cancer  
    Kucuk, O., Demirer, T., Gilan-Sachs, A., Taw, I., Mangold, M., Singh, S., Westerman, M.P, Journal of Surgical Oncology, 1/1/1993


  • Fractionated Irradiation Studies of Interferon-B as Radiosensitizer and an Antiproliferative for A549 Non-small Cell Lung Cancer Cells
    Blazek, E.R., Taw, I., and Gupta-Burt S, Radiation Research Society, 44th Annual Meeting, 4/1/1996
  • Phase I Evaluation of Cisplatin, 5-FU Infusion and WR-2721 with Radiation Therapy in Advanced Head and Neck Cancer: Protocol WR-2721-20
    Taw, I., Griem, K., Taylor, S., Recine D., Hartsell, W., and Murthy A, Proc. Of American Society for Therapeutic Radiology and Oncology 36th Annual Meeting, 10/1/1994
  • Correlation of DNA Ploidy with Stage and Histology in Prostate Cancer Patients
    Kuck, O., Demire, Y., Gilman-Sachs, A., Taw, I., Mangold, M., Joshi, H., Singh, S., Westerman, M.P, Proc. Of American Association for Cancer Research, 1/1/1991

Hospital Affiliations